44 results on '"Extracorporeal membrane oxygenation"'
Search Results
2. Early outcomes after post-cardiotomy extracorporeal membrane oxygenation in paediatric patients: a contemporary, binational cohort study.
- Author
-
Crawford, Lachlan, Marathe, Supreet P, Betts, Kim S, Karl, Tom R, Mattke, Adrian, Rahiman, Sarfaraz, Campbell, Isobella, Inoue, Takamichi, Nair, Harikrishnan, Iyengar, Ajay, Konstantinov, Igor E, Collaborative, ANZCORS, Venugopal, Prem, and Alphonso, Nelson
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *CHILD patients , *HYPOPLASTIC left heart syndrome , *COHORT analysis , *PEDIATRIC surgery , *HOSPITAL mortality - Abstract
Open in new tab Download slide OBJECTIVES The aim of this study was to assess the early outcomes and risk factors of paediatric patients requiring extracorporeal membrane oxygenation after cardiac surgery (post-cardiotomy). METHODS Retrospective binational cohort study from the Australia and New Zealand Congenital Outcomes Registry for Surgery database. All patients younger than 18 years of age who underwent a paediatric cardiac surgical procedure from 1 January 2013 to 31 December 2021 and required post-cardiotomy extracorporeal membrane oxygenation (PC-ECMO) in the same hospital admission were included in the study. RESULTS Of the 12 290 patients included in the study, 376 patients required post-cardiotomy ECMO (3%). Amongst these patients, hospital mortality was 35.6% and two-thirds of patients experienced a major complication. Hypoplastic left heart syndrome was the most common diagnosis (17%). The Norwood procedure and modified Blalock–Taussig shunts had the highest incidence of requiring PC-ECMO (odds ratio of 10 and 6.8 respectively). Predictors of hospital mortality after PC-ECMO included single-ventricle physiology, intracranial haemorrhage and chylothorax. CONCLUSIONS In the current era, one-third of patients who required PC-ECMO after paediatric cardiac surgery in Australia and New Zealand did not survive to hospital discharge. The Norwood procedure and isolated modified Blalock–Taussig shunt had the highest incidence of requiring PC-ECMO. Patients undergoing the Norwood procedure had the highest mortality (48%). Two-thirds of patients on PC-ECMO developed a major complication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Sex Differences in Vital Organ Support Provided to ICU Patients.
- Author
-
Modra, Lucy J., Higgins, Alisa M., Pilcher, David V., Bailey, Michael, and Bellomo, Rinaldo
- Subjects
- *
RENAL replacement therapy , *HOSPITAL mortality , *EXTRACORPOREAL membrane oxygenation , *NONINVASIVE ventilation , *CRITICAL care medicine - Abstract
OBJECTIVES: Critically ill women may receive less vital organ support than men but the mortality impact of this differential treatment remains unclear. We aimed to quantify sex differences in vital organ support provided to adult ICU patients and describe the relationship between sex, vital organ support, and mortality. DESIGN: In this retrospective observational study, we examined the provision of invasive ventilation (primary outcome), noninvasive ventilation, vasoactive medication, renal replacement therapy, extracorporeal membrane oxygenation (ECMO), or any one of these five vital organ supports in women compared with men. We performed logistic regression investigating the association of sex with each vital organ support, adjusted for illness severity, diagnosis, preexisting treatment limitation, year, and hospital. We performed logistic regression for hospital mortality adjusted for the same variables, stratified by vital organ support (secondary outcome). SETTING AND PATIENTS: ICU admissions in the Australia and New Zealand Intensive Care Society Adult Patient Database 2018–2021. This registry records admissions from 90% of ICUs in the two nations. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We examined 699,535 ICU admissions (43.7% women) to 199 ICUs. After adjustment, women were less likely than men to receive invasive ventilation (odds ratio [OR], 0.64; 99% CI, 0.63–0.65) and each other organ support except ECMO. Women had lower adjusted hospital mortality overall (OR, 0.94; 99% CI, 0.91–0.97). Among patients who did not receive any organ support, women had significantly lower adjusted hospital mortality (OR, 0.82; 99% CI, 0.76–0.88); among patients who received any organ support women and men were equally likely to die (OR, 1.01; 99% CI, 0.97–1.04). CONCLUSIONS: Women received significantly less vital organ support than men in ICUs in Australia and New Zealand. However, our findings suggest that women may not be harmed by this conservative approach to treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. ECPR Survivor Estimates: A Simulation-Based Approach to Comparing ECPR Delivery Strategies.
- Author
-
Kruit, Natalie, Song, Changle, Tian, David, Moylan, Emily, and Dennis, Mark
- Subjects
CARDIOPULMONARY resuscitation ,STRATEGIC planning ,MEDICAL care ,SIMULATION methods in education ,RETROSPECTIVE studies ,EXTRACORPOREAL membrane oxygenation ,MANN Whitney U Test ,T-test (Statistics) ,CARDIAC arrest ,CHI-squared test ,DATA analysis software ,EMERGENCY medicine - Abstract
Objective: The number of out-of-hospital cardiac arrest (OHCA) patients who may benefit from prehospital extracorporeal cardiopulmonary resuscitation (ECPR) is yet to be elucidated. Patient eligibility is determined both by case characteristics and physical proximity to an ECPR service. We applied accessibility principles to historical cardiac arrest data, to identify the number of patients who would have been eligible for prehospital ECPR in Sydney, Australia, and the potential survival benefit had prehospital ECPR been available. Methods: The New South Wales cardiac arrest registry between January 2017 to June 2021 included 39,387 cardiac arrests. We retrospectively defined two groups: 1) possible ECPR eligible arrests that would have triggered activation of a team, and 2) ECPR eligible arrests, those arrests that met ECPR inclusion criteria and remained refractory. Transport accessibility modeling was used to ascertain the number of arrests that would have been served by a hypothetical prehospital service and the potential survival benefit. Results: There were 699 arrests screened as possibly ECPR eligible in the Sydney metropolitan area, 488 of whom were subsequently confirmed as ECPR eligible refractory OHCA. Of these, 38% (n = 185) received intra-arrest transfer to hospital, with 37% (n = 180) arriving within 60 min. Using spatial and transport modeling, a prehospital team located at an optimal location could establish 437 (90%) patients onto ECMO within 60 min, with an estimated survival of 48% (IQR 38–57). Based on existing survival curves, compared to conventional CPR, an optimally located prehospital ECPR service has the potential to save one additional life for every 3.0 patients. Conclusions: A significant number of historical OHCA patients could have benefited from prehospital ECPR, with a potential survival benefit above conventional CPR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Measuring the Impact of ICU Strain on Mortality, After-Hours Discharge, Discharge Delay, Interhospital Transfer, and Readmission in Australia With the Activity Index.
- Author
-
Pilcher, David V., Hensman, Tamishta, Bihari, Shailesh, Bailey, Michael, McClure, Jason, Nicholls, Mark, Chavan, Shaila, Secombe, Paul, Rosenow, Melissa, Huckson, Sue, and Litton, Edward
- Subjects
- *
COVID-19 pandemic , *PATIENT readmissions , *EXTRACORPOREAL membrane oxygenation , *HOSPITAL mortality , *MORTALITY - Abstract
OBJECTIVES: ICU resource strain leads to adverse patient outcomes. Simple, well-validated measures of ICU strain are lacking. Our objective was to assess whether the “Activity index,” an indicator developed during the COVID-19 pandemic, was a valid measure of ICU strain. DESIGN: Retrospective national registry-based cohort study. SETTING: One hundred seventy-five public and private hospitals in Australia (June 2020 through March 2022). SUBJECTS: Two hundred seventy-seven thousand seven hundred thirty-seven adult ICU patients INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Data from the Australian and New Zealand Intensive Care Society Adult Patient Database were matched to the Critical Health Resources Information System. The mean daily Activity index of each ICU (census total of “patients with 1:1 nursing” + “invasive ventilation” + “renal replacement” + “extracorporeal membrane oxygenation” + “active COVID19,” divided by total staffed ICU beds) during the patient’s stay in the ICU was calculated. Patients were categorized as being in the ICU during very quiet (Activity index < 0.1), quiet (0.1 to < 0.6), intermediate (0.6 to < 1.1), busy (1.1 to < 1.6), or very busy time-periods (≥ 1.6). The primary outcome was in-hospital mortality. Secondary outcomes included after-hours discharge from the ICU, readmission to the ICU, interhospital transfer to another ICU, and delay in discharge from the ICU. Median Activity index was 0.87 (interquartile range, 0.40–1.24). Nineteen thousand one hundred seventy-seven patients died (6.9%). In-hospital mortality ranged from 2.4% during very quiet to 10.9% during very busy time-periods. After adjusting for confounders, being in an ICU during time-periods with higher Activity indices, was associated with an increased risk of in-hospital mortality (odds ratio [OR], 1.49; 99% CI, 1.38–1.60), after-hours discharge (OR, 1.27; 99% CI, 1.21–1.34), readmission (OR, 1.18; 99% CI, 1.09–1.28), interhospital transfer (OR, 1.92; 99% CI, 1.72–2.15), and less delay in ICU discharge (OR, 0.58; 99% CI, 0.55–0.62): findings consistent with ICU strain. CONCLUSIONS: The Activity index is a simple and valid measure that identifies ICUs in which increasing strain leads to progressively worse patient outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Quality care close to home: Objectives and early outcomes of a second paediatric heart transplant service in Australia.
- Author
-
Basu, Shreerupa, Irving, Claire, Roberts, Philip, Orr, Yishay, Reilly, Catherine, Casey, Charlene, Griffiths, Amelia, Oake, Diane, McElduff, Michelle, Macdonald, Peter, Nair, Priya, Jansz, Paul, and Festa, Marino
- Subjects
- *
HEART transplantation , *OPERATING room nursing , *ARTIFICIAL blood circulation , *PEDIATRICS , *EXTRACORPOREAL membrane oxygenation , *PERIOPERATIVE care - Abstract
Aim: We describe the experience of a new paediatric heart transplant (HT) centre in Australia. New South Wales offers quaternary paediatric cardiac services including comprehensive care pre‐ and post‐HT; however, perioperative HT care has previously occurred at the national paediatric centre or in adult centres. Internationally, perioperative HT care is highly protocol‐driven and a majority of HT occurs in low volume centres. Establishing a low volume paediatric HT centre in New South Wales offers potential for quality HT care close to home. Methods: Retrospective review of programme data for the first 12 months was undertaken. Patient selection was audited against the programme's intended initiation criteria. Longitudinal patient data on outcomes and complications were obtained from patient medical records. Results: The programme's initial phase offered HT to children with non‐congenital heart disease and no requirement for durable mechanical circulatory support. Eight patients met criteria for HT referral. Three underwent interstate transfer to the national paediatric centre. Five children (13–15 years, weight 36–85 kg) underwent HT in the new programme. Individual predicted 90‐day mortality was 1.3–11.6%, with increased risk for recipients transplanted from veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) and with restrictive/hypertrophic cardiomyopathies. Survival at 90 days and for duration of follow‐up is 100%. Observed programme benefits include mitigation of family dislocation and improved continuity of care within a family‐centred programme. Conclusion: Audit of the first 12 months' activity of a second paediatric HT centre in Australia demonstrates adherence to proposed patient selection criteria and excellent 90‐day patient outcomes. The programme demonstrates feasibility of care close to home, providing continuity for all patients including those requiring increased rehabilitation and psychosocial support post‐transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Inter‐hospital transfer and clinical outcomes for people with COVID‐19 admitted to intensive care units in Australia: an observational cohort study.
- Author
-
Cini, Courtney, Neto, Ary S, Burrell, Aidan, and Udy, Andrew
- Subjects
INTENSIVE care units ,EXTRACORPOREAL membrane oxygenation ,COVID-19 ,COHORT analysis ,LENGTH of stay in hospitals - Abstract
Objectives: To examine the association between inter‐hospital transfer and in‐hospital mortality among people with coronavirus disease 2019 (COVID‐19) admitted to intensive care units (ICUs) in Australia. Design: Retrospective cohort study; analysis of data collected for the Short Period Incidence Study of Severe Acute Respiratory Illness (SPRINT‐SARI) Australia study. Setting, participants: People with COVID‐19 admitted to 63 ICUs, 1 January 2020 – 1 April 2022. Main outcome measures: Primary outcome: in‐hospital mortality; secondary outcomes: ICU and hospital lengths of stay and frequency of selected complications. Results: Of 5207 people with records in the SPRINT‐SARI Australia database at 1 April 2022, 328 (6.3%) had been transferred between hospitals, 305 (93%) during the third pandemic wave. Compared with patients not transferred, their median age was lower (53 years; interquartile range [IQR], 45–61 years v 60 years; IQR, 46–70 years), their median body mass index higher (32.5 [IQR, 27.2–39.0] kg/m2v 30.1 [IQR, 25.7–35.7] kg/m2), and fewer had received a COVID‐19 vaccine (22% v 44.9%); their median APACHE II scores were similar (14.0; IQR, 12.0–18.0 v 14.0; IQR, 10.0–19.0). Bacterial pneumonia (64.7% v 29.0%) and bacteraemia (27% v 8%) were more frequent in transferred patients, as was the need for more intensive ICU interventions, including invasive mechanical ventilation (71.2% v 38.1%) and extra‐corporeal membrane oxygenation (26% v 1.7%). Crude ICU (19% v 14.9%) and in‐hospital mortality (19% v 18.4%) were similar for patients who were or were not transferred; median lengths of ICU (20.0 [IQR, 11.2–40.3] days v 4.6 [IQR, 2.1–10.1] days) and hospital stay (29.7 [IQR, 18.1–49.6] days v 12.3 [IQR, 7.3–21.0] days) were longer for transferred patients. In the multivariable regression analysis, in‐hospital mortality risk was lower for transferred patients (risk difference [RD], –5.0 percentage points; 95% confidence interval [CI] –10 to –0.03 percentage points), but not in the propensity score‐adjusted analysis (RD, –3.4 [95% CI, –8.9 to 2.1] percentage points). Conclusions: Among people with COVID‐19 admitted to ICUs, patients transferred from another hospital required more intense interventions and remained in hospital longer, but were not at greater risk of dying in hospital than the patients who were not transferred. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. The Australia and New Zealand Congenital Outcomes Registry for Surgery (ANZCORS): methodology and preliminary results.
- Author
-
Marathe, Supreet P., Suna, Jessica, Betts, Kim S., Merlo, Greg, Konstantinov, Igor E., Iyengar, Ajay J., Venugopal, Prem, and Alphonso, Nelson
- Subjects
- *
TREATMENT effectiveness , *PEDIATRIC surgery , *SURGICAL complications , *CARDIAC surgery , *EXTRACORPOREAL membrane oxygenation , *CARDIOPULMONARY bypass - Abstract
Background: Analysis of multi‐institutional data and benchmarking is an accepted accreditation standard in cardiac surgery. Such a database does not exist for congenital cardiac surgery in Australia and New Zealand (ANZ). To fill this gap, the ANZ Congenital Outcomes Registry for Surgery (ANZCORS) was established in 2017. Methods: Inclusion criteria included all cardiothoracic and extracorporeal membrane oxygenation (ECMO) procedures performed at five participating centres. Data was collected by data managers, validated by the surgical team, and securely transmitted to a central repository. Results: Between 2015 and 2019, 9723 procedures were performed in 7003 patients. Cardiopulmonary bypass was utilized for 59% and 9% were ECMO procedures. Fifty‐seven percent (n = 5531) of the procedures were performed in children younger than 1 year of age. Twenty‐four percent of procedures (n = 2365) were performed in neonates (≤28 days) and 33% (n = 3166) were performed in children aged 29 days to 1 year (infants). The 30‐day mortality for cardiac cases (n = 6572) was 1.3% and there was no statistical difference between the participating centres (P = 0.491). Sixty‐nine percent of cases had no major post‐operative complications (5121/7456). For cardiopulmonary bypass procedures (n = 5774), median stay in intensive care and hospital was 2 days (IQR 1, 4) and 9 days (IQR 5, 18), respectively. Conclusion: ANZCORS has facilitated pooled data analysis for paediatric cardiac surgery across ANZ for the first time. Overall mortality was low. Non‐risk‐adjusted 30‐day mortality for individual procedures was similar in all units. The continued evaluation of surgical outcomes through ANZCORS will drive quality assessment in paediatric cardiac surgery across ANZ. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study.
- Author
-
Hodgson, Carol L, Higgins, Alisa M, Bailey, Michael J, Anderson, Shannah, Bernard, Stephen, Fulcher, Bentley J, Koe, Denise, Linke, Natalie J, Board, Jasmin V, Brodie, Daniel, Buhr, Heidi, Burrell, Aidan J C, Cooper, D James, Fan, Eddy, Fraser, John F, Gattas, David J, Hopper, Ingrid K, Huckson, Sue, Litton, Edward, and McGuinness, Shay P
- Subjects
CRITICALLY ill ,EXTRACORPOREAL membrane oxygenation ,APACHE (Disease classification system) ,PATIENT selection - Abstract
Extracorporeal membrane oxygenation (ECMO) is an invasive procedure used to support critically ill patients with the most severe forms of cardiac or respiratory failure in the short term, but long-term effects on incidence of death and disability are unknown. We aimed to assess incidence of death or disability associated with ECMO up to 6 months (180 days) after treatment. This prospective, multicentre, registry-embedded cohort study was done at 23 hospitals in Australia from Feb 15, 2019, to Dec 31, 2020. The EXCEL registry included all adults (≥18 years) in Australia who were admitted to an intensive care unit (ICU) in a participating centre at the time of the study and who underwent ECMO. All patients who received ECMO support for respiratory failure, cardiac failure, or cardiac arrest during their ICU stay were eligible for this study. The primary outcome was death or moderate-to-severe disability (defined using the WHO Disability Assessment Schedule 2.0, 12-item survey) at 6 months after ECMO initiation. We used Fisher's exact test to compare categorical variables. This study is registered with ClinicalTrials.gov , NCT03793257. Outcome data were available for 391 (88%) of 442 enrolled patients. The primary outcome of death or moderate-to-severe disability at 6 months was reported in 260 (66%) of 391 patients: 136 (67%) of 202 who received veno-arterial (VA)-ECMO, 60 (54%) of 111 who received veno-venous (VV)-ECMO, and 64 (82%) of 78 who received extracorporeal cardiopulmonary resuscitation (eCPR). After adjustment for age, comorbidities, Acute Physiology and Chronic Health Evaluation (APACHE) IV score, days between ICU admission and ECMO start, and use of vasopressors before ECMO, death or moderate-to-severe disability was higher in patients who received eCPR than in those who received VV-ECMO (VV-ECMO vs eCPR: risk difference [RD] –32% [95% CI –49 to –15]; p<0·001) but not VA-ECMO (VA-ECMO vs eCPR –8% [–22 to 6]; p=0·27). In our study, only a third of patients were alive without moderate-to-severe disability at 6 months after initiation of ECMO. The finding that disability was common across all areas of functioning points to the need for long-term, multidisciplinary care and support for surviving patients who have had ECMO. Further studies are needed to understand the 180-day and longer-term prognosis of patients with different diagnoses receiving different modes of ECMO, which could have important implications for the selection of patients for ECMO and management strategies in the ICU. The National Health and Medical Research Council of Australia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Nutrition adequacy, gastrointestinal, and hepatic function during extracorporeal membrane oxygenation in critically ill adults: A retrospective observational study.
- Author
-
Visvalingam, Rozanne, Ridley, Emma, Barnett, Adrian, Rahman, Tony, and Fraser, John F.
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *MECONIUM aspiration syndrome , *SYSTEMIC inflammatory response syndrome , *CRITICALLY ill , *NUTRITION , *WATER-electrolyte balance (Physiology) - Abstract
Aims: To identify clinical and biochemical markers associated with nutrition adequacy and gastrointestinal and liver dysfunction in adults on extracorporeal membrane oxygenation (ECMO). Methods: A retrospective, observational, study was conducted at 2 centres in Australia. Adult patients who received ECMO from July 2011 to June 2015 were included. Mode of ECMO used, fluid balance, number of systemic inflammatory response syndrome (SIRS) criteria present, vasoactive‐inotropic scores (VIS) and liver function tests (LFTs) were collected for the duration of ECMO until 7 days after ECMO cessation. Multiple regression models were used to determine if the collected variables were associated with nutrition adequacy. The mean LFTs during ECMO were also compared to mean LFTs post ECMO cessation. Results: During the first 5 days of ECMO commencement, mean nutrition adequacy was 10% higher in the veno‐venous (VV) ECMO group than in the veno‐arterial (VA) group (95% confidence interval [CI], 2% to 17%). For every 5000 ml increase of fluid balance, an associated decrease in nutrition adequacy was observed (−8%, 95% CI: −15% to −2%). A doubling of bilirubin and VIS were associated with a mean reduction in nutrition adequacy of −5% (95% CI –8% to −2%) and − 2% (95% CI: −3% to −1%), respectively. Conclusions: In the first 5 days of ECMO commencement, higher nutrition adequacy was associated with the VV mode of ECMO and reduced nutrition adequacy with increased fluid balance, more vasopressor and inotropic support and raised bilirubin. Prospective investigation is required to confirm whether these associations have a causal relationship. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Findings from Monash University in the Area of Respiratory Therapy Reported (Conservative or Liberal Oxygen Targets In Patients On Venoarterial Extracorporeal Membrane Oxygenation).
- Subjects
RESPIRATORY therapy ,EXTRACORPOREAL membrane oxygenation ,MEDICAL rehabilitation ,CRITICAL care medicine ,INTENSIVE care units - Abstract
A study conducted by Monash University in Melbourne, Australia examined the effects of different oxygen saturation targets on patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO) in the intensive care unit (ICU). The study randomly assigned adult patients to either a conservative oxygen strategy (targeting SaO2 levels of 92-96%) or a liberal oxygen strategy (targeting SaO2 levels of 97-100%). The study found that there was no significant difference in the number of ICU-free days to day 28 between the two groups. The study concluded that a conservative oxygen strategy did not affect outcomes for patients on VA-ECMO. [Extracted from the article]
- Published
- 2024
12. Low volume ECMO results study
- Author
-
Joyce, Christopher J, Cook, David A, Walsham, James, Krishnan, Anand, Lo, Wingchi, Samaan, John, Semark, Andrew J, Pearson, David C, Stroebel, Andrie, Provenzano, Sylvio, McKeague, Ronan, and Winearls, James R
- Published
- 2020
13. An exploration of intensive care nurses' perceptions of workload in providing extracorporeal membrane oxygenation (ECMO) support: A descriptive qualitative study.
- Author
-
Ross P, Sheldrake J, Ilic D, Watterson J, Berkovic D, Pilcher D, Udy A, and Hodgson CL
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Intensive Care Units, Australia, Attitude of Health Personnel, Extracorporeal Membrane Oxygenation, Qualitative Research, Workload, Critical Care Nursing, Interviews as Topic
- Abstract
Background: There is increasing use of extracorporeal membrane oxygenation (ECMO) in intensive care, where nurses provide the majority of the required ongoing care of cannulas, circuit, and console. Limited evidence currently exists that details nursing perspectives, experiences, and challenges with workload in the provision of ECMO care., Objective: The objective of this study was to investigate intensive care nurses' perceptions of workload in providing specialist ECMO therapy and care in a high-volume ECMO centre., Methods: The study used a qualitative descriptive methodology through semistructured interviews. Data were analysed using an inductive thematic analysis approach following Braun and Clarke's iterative process. This study was conducted in an intensive care unit within an Australian public, quaternary, university-affiliated hospital, which provides specialist state-wide service for ECMO., Findings: Thirty ECMO-specialist trained intensive care nurses were interviewed. This study identified three key themes: (i) opportunity; (ii) knowledge and responsibilities; and (iii) systems and structures impacting on intensive care nurses' workload in providing ECMO supportive therapy., Conclusions: Intensive care nurses require advanced clinical and critical thinking skills. Intensive care nurses are motivated and engaged to learn and acquire ECMO skills and competency as part of their ongoing professional development. Providing bedside ECMO management requires constant monitoring and surveillance from nurses to care for the one of the most critically unwell patient populations in the intensive care unit setting. As such, ECMO nursing services require a suitably trained and educated workforce of intensive care trained nurses. ECMO services provide clinical development opportunities for nurses, increase their scope of practice, and create advanced practice-specialist roles., (Copyright © 2023 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Retrieval of neonatal and paediatric patients on extracorporeal membrane oxygenation support in New South Wales, Australia.
- Author
-
Browning Carmo, Kathryn A, Liava'a, Matthew, Festa, Marino, Fa'asalele, Thelma A, Roxburgh, Jane, Bladwell, Wendy, McGeever, Jenna, Griffiths, Amelia, O'Shaughnessy, Killian, and Berry, Andrew
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *CHILD patients , *CARDIOGENIC shock - Abstract
New South Wales has recently added the capability of extracorporeal membrane oxygenation to the neonatal and paediatric retrieval process and this paper describes the early experiences and protocol development for the first eight cases transported. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Predictors of mortality after extracorporeal cardiopulmonary resuscitation
- Author
-
Zakhary, Bishoy, Nanjayya, Vinodh B, Sheldrake, Jayne, Collins, Kathleen, Ihle, Joshua F, and Pellegrino, Vincent
- Published
- 2018
16. Post Cardiotomy Extra Corporeal Membrane Oxygenation: Australian Cohort Review.
- Author
-
Farag, James, Summerhayes, Robyn, Shen, Rong, Bailey, Michael, Williams-Spence, Jenni, Reid, Christopher M., and Marasco, Silvana F.
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *LOGISTIC regression analysis , *HOSPITAL mortality , *ACQUISITION of data , *CARDIAC surgery , *CARDIOPULMONARY bypass , *RESEARCH , *RESEARCH methodology , *RETROSPECTIVE studies , *DISEASES , *PROGNOSIS , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies , *HEART diseases ,HEART disease epidemiology - Abstract
Background: Over the last two decades, technological advancements in the delivery of extra corporeal membrane oxygenation (ECMO) have seen its use broaden and results improve. However, in the post cardiotomy ECMO patient group, survival remains very poor without significant improvements over the last two decades. Our study aims to report on the Australian experience, with the intention of providing background data for the formation of guidelines in the future.Methods: Retrospective analysis of prospectively collected data from the Australian and New Zealand Society of Cardiothoracic Surgeons (ANZSCTS) Database was performed. The ANZSCTS database captures at least 60% of cardiac surgical data in Australia, annually. Data was collected on adult patients who received ECMO post cardiotomy from September 2016 to November 2017 inclusive. Transplant and primary cardiomyopathy patients were excluded.Results: Of the 16,605 adult patients undergoing cardiac surgery in the 15-month period of the study, 87 patients required post cardiotomy ECMO (0.52%). The average age of the entire cohort was 56 years. Overall survival to discharge was 43.7% (n=38). Multivariable logistic regression analysis demonstrated that multiorgan failure (MOF), increasing age and longer cardiopulmonary bypass time were significant predictors of in hospital mortality.Conclusions: Post cardiotomy ECMO support is an uncommon condition. Survival in this study appears to be better than historical reports. Identification of poor prognostic indicators in this study may help inform the development of guidelines for the most appropriate use of this support modality. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
17. Data on Respiratory Therapy Discussed by Researchers at Prince Charles Hospital (A Mock Circulation Loop To Evaluate Differential Hypoxemia During Peripheral Venoarterial Extracorporeal Membrane Oxygenation).
- Subjects
EXTRACORPOREAL membrane oxygenation ,RESPIRATORY therapy ,RESEARCH personnel ,HYPOXEMIA ,PRINCES - Abstract
Researchers at Prince Charles Hospital in Brisbane, Australia have presented data on respiratory therapy. The research focuses on peripheral veno-arterial extracorporeal membrane oxygenation (VA ECMO) and its impact on differential hypoxemia (DH). The researchers developed a mock circulation loop (MCL) to study DH and its effects on the brain and coronary arteries. The MCL was able to reproduce relevant mixing zones within the aortic arch, making it a potential alternative to animal studies for research scenarios. The research has been peer-reviewed and published in the journal Perfusion. [Extracted from the article]
- Published
- 2024
18. Gestational Age and Risk of Mortality in Term-Born Critically Ill Neonates Admitted to PICUs in Australia and New Zealand.
- Author
-
Namachivayam, Siva P., Carlin, John B., Millar, Johnny, Alexander, Janet, Edmunds, Sarah, Ganeshalingham, Anusha, Lew, Jamie, Erickson, Simon, Butt, Warwick, Schlapbach, Luregn J., Ganu, Subodh, Festa, Marino, Egan, Jonathan R., Williams, Gary, Young, Janelle, and Australian and New Zealand Intensive Care Society Paediatric Study Group (ANZICS PSG) and Australian and New Zealand Paediatric Intensive Care Registry (ANZPICR)
- Subjects
- *
GESTATIONAL age , *EXTRACORPOREAL membrane oxygenation , *LENGTH of stay in hospitals , *NEWBORN infants , *CRITICALLY ill - Abstract
Objectives: Gestational age at birth is declining, probably because more deliveries are being induced. Gestational age is an important modifiable risk factor for neonatal mortality and morbidity. We aimed to investigate the association between gestational age and mortality in hospital for term-born neonates (≥ 37 wk') admitted to PICUs in Australia and New Zealand.Design: Observational multicenter cohort study.Setting: PICUs in Australia and New Zealand.Patients: Term-born neonates (≥ 37 wk') admitted to PICUs.Interventions: None MEASUREMENTS AND MAIN RESULTS:: We studied 5,073 infants born with a gestational age greater than or equal to 37 weeks and were less than 28 days old when admitted to a PICU in Australia or New Zealand between 2007 and 2016. The association between gestational age and mortality was estimated using a multivariable logistic regression model, adjusting for age, sex, indigenous status, Pediatric Index of Mortality version 2, and site. The median gestational age was 39.1 weeks (interquartile range, 38.2-40 wk) and mortality in hospital was 6.6%. Risk of mortality declined log-linearly with gestational age. The adjusted analysis showed a 20% (95% CI, 11-28%) relative reduction in mortality for each extra week of gestation beyond 37 weeks. The effect of gestation was stronger among those who received extracorporeal life support: each extra week of gestation was associated with a 44% (95% CI, 25-57%) relative reduction in mortality. Longer gestation was also associated with reduced length of stay in hospital: each week increase in gestation, the average length of stay decreased by 4% (95% CI, 2-6%).Conclusions: Among neonates born at "term" who are admitted to a PICU, increasing gestational age at birth is associated with a substantial reduction in the risk of dying in hospital. The maturational influence on outcome was more strongly noted in the sickest neonates, such as those requiring extracorporeal life support. This information is important in view of the increasing proportion of planned births in both high- and low-/middle-income countries. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
19. Surge capacity of intensive care units in case of acute increase in demand caused by COVID-19 in Australia.
- Author
-
Litton, Edward, Bucci, Tamara, Chavan, Shaila, Ho, Yvonne Y, Holley, Anthony, Howard, Gretta, Huckson, Sue, Kwong, Philomena, Millar, Johnny, Nguyen, Nhi, Secombe, Paul, Ziegenfuss, Marc, and Pilcher, David
- Subjects
INTENSIVE care units ,COVID-19 ,EXTRACORPOREAL membrane oxygenation ,CRITICAL care medicine ,NURSE practitioners - Abstract
Objectives: To assess the capacity of intensive care units (ICUs) in Australia to respond to the expected increase in demand associated with COVID-19.Design: Analysis of Australian and New Zealand Intensive Care Society (ANZICS) registry data, supplemented by an ICU surge capability survey and veterinary facilities survey (both March 2020).Settings: All Australian ICUs and veterinary facilities.Main Outcome Measures: Baseline numbers of ICU beds, ventilators, dialysis machines, extracorporeal membrane oxygenation machines, intravenous infusion pumps, and staff (senior medical staff, registered nurses); incremental capability to increase capacity (surge) by increasing ICU bed numbers; ventilator-to-bed ratios; number of ventilators in veterinary facilities.Results: The 191 ICUs in Australia provide 2378 intensive care beds during baseline activity (9.3 ICU beds per 100 000 population). Of the 175 ICUs that responded to the surge survey (with 2228 intensive care beds), a maximal surge would add an additional 4258 intensive care beds (191% increase) and 2631 invasive ventilators (120% increase). This surge would require additional staffing of as many as 4092 senior doctors (245% increase over baseline) and 42 720 registered ICU nurses (269% increase over baseline). An additional 188 ventilators are available in veterinary facilities, including 179 human model ventilators.Conclusions: The directors of Australian ICUs report that intensive care bed capacity could be near tripled in response to the expected increase in demand caused by COVID-19. But maximal surge in bed numbers could be hampered by a shortfall in invasive ventilators and would also require a large increase in clinician and nursing staff numbers. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
20. Development and testing of a low cost simulation manikin for extracorporeal cardiopulmonary resuscitation (ECPR) using 3-dimensional printing.
- Author
-
Pang, G., Futter, C., Pincus, J., Dhanani, J., and Laupland, K.B.
- Subjects
- *
CARDIOPULMONARY resuscitation , *BLOOD vessels , *AUSTRALIAN dollar , *THREE-dimensional printing , *COST estimates , *3-D printers , *CRITICAL care medicine , *RESEARCH , *RESEARCH methodology , *EXTRACORPOREAL membrane oxygenation , *HUMAN anatomical models , *MEDICAL cooperation , *EVALUATION research , *COMPARATIVE studies - Abstract
Background: There has been an explosive growth of ECPR within new and established ECMO programs worldwide with the concomitant need for simulation trainers. However, current commercially available ECMO simulation models are expensive and lack many standard cardiorespiratory resuscitative (CPR) features.Objective: To use 3-dimensional (3D) printing to develop a training manikin for comprehensive ECPR simulation.Methods: A standard commercially available CPR manikin with airway model was used as the base model for modification. An inexpensive 3D printer was used to print a modular plastic pelvis. A medical silicone gel incorporated silicone femoral vasculature component was manufactured with connection to a gravity fed vascular system.Results: The resulting modified manikin included the modular in-house designed ECMO cannulation and vascular structures wedded to the commercially available airway and CPR components. In simulation exercise involving first responders, paramedics, and emergency and critical care physicians, the model was reported as realistic with ultrasound views, cannulation, and resuscitative components functional. The entire cost for development of the ECMO component was estimated at $2000 Australian dollars AUD, including the printer purchase and supplies. Future reuse of components is estimated to cost less than $5 AUD per simulation run.Conclusions: A novel in-house modified manikin for ECPR was developed that was cost-efficient and realistic to use from first response through to establishment of ECMO circulation. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
21. Prehospital extracorporeal cardiopulmonary resuscitation for out‐of‐hospital cardiac arrest: A retrospective eligibility study.
- Author
-
Kilner, Thomas, Stanton, Benjamin L, and Mazur, Stefan M
- Subjects
- *
CARDIAC arrest , *CONFIDENCE intervals , *CARDIOPULMONARY resuscitation , *EMERGENCY medical services , *EMERGENCY medicine , *EXTRACORPOREAL membrane oxygenation , *ELIGIBILITY (Social aspects) , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *ODDS ratio - Abstract
Objective: We sought to identify out‐of‐hospital cardiac arrest (OOHCA) patients who might benefit from a future prehospital extracorporeal cardiopulmonary resuscitation (ECPR) programme in a moderately sized city. We described the 2014 OOHCA data and identified those who fulfilled hypothetical prehospital ECPR eligibility criteria. Methods: We identified patients aged 18–65 years in cardiac arrest, where CPR was commenced by paramedics on arrival. Traumatic cardiac arrest and end‐of‐life needs were patient exclusions. Patients were then included in one of three hypothetical 'ECPR eligible' groups. Patients were included in an 'ECPR eligible' group if they met author agreed criteria. Select patients in refractory VT/VF; pulseless electrical activity (PEA); and non‐refractory VT/VF, or asystole with subsequent VT/VF or transient return of spontaneous circulation (ROSC), were assigned to three separate groups. Descriptive statistics were applied to each group. Outcomes of ECPR eligible patients who developed sustained ROSC after 20 min of conventional CPR were characterised. Results: A total of 206 patients were included. A significant positive association between initial shockable rhythm (odds ratio [OR] 15.32, confidence interval [CI] 5.4–43.2) and sustained ROSC, and PEA (OR 6.93, CI 2.4–19.8) and sustained ROSC, versus asystole was identified (P < 0.001). Sixty‐eight (33%) patients were eligible for one of the hypothetical ECPR groups. Twelve (17.6%) of the 68 ECPR eligible patients developed sustained ROSC after 20 min of conventional CPR, with only two surviving neurologically intact to hospital discharge. Conclusion: Sixty‐three (30.6%) patients could have derived benefit from a prehospital ECPR programme. Further analyses of prehospital ECPR logistics and economics are necessary to ensure that any future prehospital ECPR programme is effective and efficient. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
22. Incremental research approach to describing the pharmacokinetics of ciprofl oxacin during extracorporeal membrane oxygenation
- Author
-
Sinnah, Fabrice, Shekar, Kiran, Abdul-Aziz, Mohd H, Buscher, Hergen, Diab, Sara D, Fisquet, Stephanie, Fung, Yoke L, McDonald, Charles I, Reynolds, Claire, Rudham, Sam, Wallis, Steven C, Welch, Susan, Xie, Jiao, Fraser, John F, and Roberts, Jason A
- Published
- 2017
23. Nosocomial infections acquired by patients treated with extracorporeal membrane oxygenation
- Author
-
Austin, Danielle E, Kerr, Stephen J, Al-Soufi, Suhel, Connellan, Mark, Spratt, Phillip, Goeman, Emma, and Nair, Priya
- Published
- 2017
24. Service delivery model of extracorporeal membrane oxygenation in an Australian regional hospital
- Author
-
McCaffrey, Joe, Orford, Neil R, Simpson, Nicholas, Jenkins, Jill Lamb, Morley, Christopher, and Pellegrino, Vin
- Published
- 2016
25. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest in Australia: a narrative review.
- Author
-
Dennis M, Shekar K, and Burrell AJ
- Subjects
- Humans, Australia epidemiology, Retrospective Studies, Extracorporeal Membrane Oxygenation, Cardiopulmonary Resuscitation, Out-of-Hospital Cardiac Arrest therapy, Emergency Medical Services
- Abstract
Extracorporeal cardiopulmonary resuscitation (ECPR) in patients with prolonged or refractory out-of-hospital cardiac arrest (OHCA) is likely to be beneficial when used as part of a well developed emergency service system. ECPR is technically challenging to initiate and resource-intensive, but it has been found to be cost-effective in hospital-based ECPR programs. ECPR expansion within Australia has thus far been reactive and does not provide broad coverage or equity of access for patients. Newer delivery strategies that improve access to ECPR for patients with OHCA are being trialled, including networked hospital-based ECPR and pre-hospital ECPR programs. The efficacy, scalability, sustainability and cost-effectiveness of these programs need to be assessed. There is a need for national collaboration to determine the most cost-effective delivery strategies for ECPR provision along with its place in the OHCA survival chain., (© 2023 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
26. The effect of restrictive versus liberal selection criteria on survival in ECPR: a retrospective analysis of a multi-regional dataset.
- Author
-
Diehl A, Read AC, Southwood T, Buscher H, Dennis M, Nanjayya VB, and Burrell AJC
- Subjects
- Humans, Australia epidemiology, Patient Selection, Retrospective Studies, Treatment Outcome, Cardiopulmonary Resuscitation methods, Extracorporeal Membrane Oxygenation methods, Out-of-Hospital Cardiac Arrest therapy
- Abstract
Background: Extracorporeal cardiopulmonary resuscitation (ECPR) is an established rescue therapy for both out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA). However, there remains significant heterogeneity in populations and outcomes across different studies. The primary aim of this study was to compare commonly used selection criteria and their effect on survival and utilisation in an Australian ECPR cohort., Methods: We performed a retrospective, observational study of three established ECPR centres in Australia, including cases from 1 January 2013 to 31 December 2020 to establish the baseline cohort. We applied five commonly used ECPR selection criteria, ranging from restrictive to liberal., Results: The baseline cohort included 199 ECPR cases: 95 OHCA and 104 IHCA patients. Survival to hospital discharge was 20% for OHCA and 41.4% for IHCA. For OHCA patients, strictly applying the most restrictive criteria would have resulted in the highest survival rate 7/16 (43.8%) compared to the most liberal criteria 16/73 (21.9%). However, only 16/95 (16.8%) in our cohort strictly met the most restrictive criteria versus 73/95 (76.8%) with the most liberal criteria. Similarly, in IHCA, the most restrictive criteria would have resulted in a higher survival rate in eligible patients 10/15 (66.7%) compared to 27/59 (45.8%) with the most liberal criteria. With all criteria a large portion of survivors in IHCA would not have been eligible for ECMO if strictly applying criteria, 33/43 (77%) with restrictive and 16/43 (37%) with the most liberal criteria., Conclusions: Adherence to different selection criteria impacts both the ECPR survival rate and the total number of survivors. Commonly used selection criteria may be unsuitable to select IHCA ECPR patients., (© 2023. Crown.)
- Published
- 2023
- Full Text
- View/download PDF
27. Cost effectiveness and quality of life analysis of extracorporeal cardiopulmonary resuscitation (ECPR) for refractory cardiac arrest.
- Author
-
Dennis, Mark, Zmudzki, Fredrick, Burns, Brian, Scott, Sean, Gattas, David, Reynolds, Claire, Buscher, Hergen, Forrest, Paul, and Sydney ECMO Research Interest Group
- Subjects
- *
COST effectiveness , *CARDIAC arrest , *CARDIOPULMONARY resuscitation , *COST analysis , *QUALITY of life , *COMPARATIVE studies , *EXTRACORPOREAL membrane oxygenation , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *EVALUATION research , *RETROSPECTIVE studies , *QUALITY-adjusted life years - Abstract
Background: The use of extracorporeal membrane oxygenation (ECMO) in refractory cardiac arrest (ECPR) has increased exponentially. ECPR is a resource intensive service and its cost effectiveness has yet to be demonstrated. We sought to complete a cost analysis with modelling of cost effectiveness and quality of life outcomes. We sought to complete a cost analysis with modelling of cost effectiveness and quality of life outcomes of patients who have undergone ECPR.Methods: Using data on all extracorporeal cardiopulmonary resuscitation (ECPR) patients at two ECMO centres in Sydney, Australia; we completed a costing analysis of ECPR patients. A Markov model of cost, quality of life and survival outcomes was developed to examine cost per QALY estimates and incremental cost effectiveness ratios (ICERs). Probabilistic sensitivity analysis (PSA) was completed to assess the probability of cost effectiveness for base case and variations.Results: Sixty-two consecutive ECPR patients were analysed; mean age of 51.9 ± 13.6 years, 38 (61%) were in hospital cardiac arrests (IHCA). Twenty-five patients (40%) survived to hospital discharge; all with a cerebral performance category (CPC) of 1 or 2. The mean cost per ECPR patient was AUD 75,165 (€50,535; ±AUD 75,737). Over 10 years ECPR was estimated to add a mean gain of 3.0 Quality Adjusted Life Years (QALYs) per patient with an incremental cost effectiveness ratio (ICER) of AUD 25,212 (€16,890) per QALY, increasing to 4.0 QALYs and an ICER of AUD 18,829 (€12,614) over a 15-year survival scenario. Mean cost per QALY did not differ significantly by OHCA or IHCA.Conclusions: ECMO support for refractory cardiac arrests is cost effective and compares favourably to accepted cost effectiveness thresholds. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
28. Outcomes of Donation After Circulatory Death Heart Transplantation in Australia.
- Author
-
Chew, Hong Chee, Iyer, Arjun, Connellan, Mark, Scheuer, Sarah, Villanueva, Jeanette, Gao, Ling, Hicks, Mark, Harkness, Michelle, Soto, Claudio, Dinale, Andrew, Nair, Priya, Watson, Alasdair, Granger, Emily, Jansz, Paul, Muthiah, Kavitha, Jabbour, Andrew, Kotlyar, Eugene, Keogh, Anne, Hayward, Chris, and Graham, Robert
- Subjects
- *
HEART transplantation , *EXTRACORPOREAL membrane oxygenation , *HEART assist devices , *KIDNEY exchange , *AUSTRALIAN authors , *ELECTRONIC records - Abstract
Background: Transplantation of hearts retrieved from donation after circulatory death (DCD) donors is an evolving clinical practice.Objectives: The purpose of this study is to provide an update on the authors' Australian clinical program and discuss lessons learned since performing the world's first series of distantly procured DCD heart transplants.Methods: The authors report their experience of 23 DCD heart transplants from 45 DCD donor referrals since 2014. Donor details were collected using electronic donor records (Donate Life, Australia) and all recipient details were collected from clinical notes and electronic databases at St. Vincent's Hospital.Results: Hearts were retrieved from 33 of 45 DCD donors. A total of 12 donors did not progress to circulatory arrest within the pre-specified timeframe. Eight hearts failed to meet viability criteria during normothermic machine perfusion, and 2 hearts were declined due to machine malfunction. A total of 23 hearts were transplanted between July 2014 and April 2018. All recipients had successful implantation, with mechanical circulatory support utilized in 9 cases. One case requiring extracorporeal membrane oxygenation subsequently died on the sixth post-operative day, representing a mortality of 4.4% over 4 years with a total follow-up period of 15,500 days for the entire cohort. All surviving recipients had normal cardiac function on echocardiogram and no evidence of acute rejection on discharge. All surviving patients remain in New York Heart Association functional class I with normal biventricular function.Conclusions: DCD heart transplant outcomes are excellent. Despite a higher requirement for mechanical circulatory support for delayed graft function, primarily in recipients with ventricular assist device support, overall survival and rejection episodes are comparable to outcomes from contemporary brain-dead donors. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
29. Data on Health and Medicine Reported by Johnny Millar and Colleagues (Thirty years of ANZICS CORE: A clinical quality success story).
- Subjects
PEDIATRIC intensive care ,EXTRACORPOREAL membrane oxygenation ,INTENSIVE care units ,COVID-19 pandemic - Abstract
Keywords: Victoria; Australia; Australia and New Zealand; Clinical Medicine; Health and Medicine; Pediatrics; Prognosis EN Victoria Australia Australia and New Zealand Clinical Medicine Health and Medicine Pediatrics Prognosis 125 125 1 11/06/23 20231110 NES 231110 2023 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Pediatrics Week -- New research on Health and Medicine is the subject of a report. Victoria, Australia, Australia and New Zealand, Clinical Medicine, Health and Medicine, Pediatrics, Prognosis. [Extracted from the article]
- Published
- 2023
30. Nutrition therapy in adult patients receiving extracorporeal membrane oxygenation: A prospective, multicentre, observational study
- Author
-
Ridley, Emma J, Davies, Andrew R, Robins, Elissa J, Lukas, George, Bailey, Michael J, and Fraser, John F
- Published
- 2015
31. Haemorrhagic bronchial casts causing complete ventilatory failure in a COVID-19 patient on ECMO.
- Author
-
Herath, Samantha, Kruit, Natalie, Eslick, Adam, and Giroy, Nicole
- Subjects
- *
COVID-19 , *EXTRACORPOREAL membrane oxygenation , *ARGON plasmas , *SYMPTOMS - Abstract
Coronavirus disease 2019 (COVID-19) was identified as causing an unusual pneumonia in Wuhan in late 2019 and rapidly evolved to a pandemic. We present a case of an otherwise well 55-year-old female patient who had seemingly mild symptoms when she presented to the emergency department, and then rapidly deteriorated with progressive ventilatory deficit requiring intubation, ventilation, and extracorporeal membrane oxygenation (ECMO). We present the surprise finding of haemorrhagic endobronchial casts in the airways causing a complete ventilatory failure, managed by cryobiopsy and argon plasma coagulation (APC) leading to improved ventilation. To our knowledge, this is the only patient placed on ECMO for COVID-19 infection in Australia and we would like to highlight the complications and challenges when trying to manage pulmonary haemorrhagic casts whilst on ECMO. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Extracorporeal membrane oxygenation and Extracorporeal Membrane Oxygenation Cardiopulmonary Resusciation (ECPR) research priorities in Australia: A clinician survey.
- Author
-
Dennis M, Southwood TJ, Oliver M, Nichol A, Burrell A, and Hodgson C
- Subjects
- Humans, Prospective Studies, Australia, Surveys and Questionnaires, Research, Retrospective Studies, Extracorporeal Membrane Oxygenation, Cardiopulmonary Resuscitation
- Abstract
Background: The use of extracorporeal membrane oxygenation (ECMO) for cardiorespiratory failure and during cardiopulmonary resuscitation has increased significantly and is resource intensive. High-quality evidence to guide management of patients on ECMO is limited., Objectives: The objective of this study was to determine the research priorities of clinicians for ECMO and Extracorporeal Membrane Oxygenation Cardiopulmonary Resusciation (ECPR) in Australia and New Zealand., Methods: A prospective, binational survey of clinicians was conducted in May 2022., Results: There were 133 respondents; 110 (84%) worked at an Australian ECMO centre; 28 (21%) were emergency, 45 (34%) were intensive care, and 41 (31%) were nursing clinicians. All aspects of ECMO care were identified by respondents as being important for further research; however, appropriate patient selection and determining long-term outcomes were ranked the highest. While most believed ECMO was efficacious, they felt that there was insufficient evidence to determine cost-effectiveness. There was uncertainty of the best model of ECPR provision. Equipoise exists for randomised studies into anticoagulation, blood product usage, and ECPR., Conclusions: This survey found strong support amongst clinicians for further research into the optimal use of ECMO and ECPR and provides a frame work for prioritising future clinical trials and research agendas., Competing Interests: Conflict of interest The authors report no conflict of interest., (Copyright © 2022 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. Use of extracorporeal membrane oxygenation in cystic fibrosis in an Australian cystic fibrosis centre.
- Author
-
Sivam, Sheila, Dentice, Ruth, Reddy, Nazmeen, Moriarty, Carmel, Yozghatlian, Veronica, Mellis, Craig, Torzillo, Paul, Glanville, Allan, Gattas, David, and Bye, Peter
- Subjects
- *
CYSTIC fibrosis treatment , *EXTRACORPOREAL membrane oxygenation , *HEALTH facilities , *LUNG transplantation , *RESPIRATORY insufficiency , *TIME , *TREATMENT effectiveness , *PATIENT selection - Abstract
Abstract: Extracorporeal membrane oxygenation (ECMO) support is used in selected patients with cystic fibrosis (CF) as a bridge to transplantation. Our aim was to describe briefly treatment and outcomes of six CF patients who received ECMO. One patient received a lung transplant and another recovered from acute respiratory failure. Four died despite ECMO support. Lack of timely availability of suitable donor lungs and patient selection are contributing factors. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
34. IN THIS FEBRUARY ISSUE.
- Author
-
HUGHES, Geoff
- Subjects
- *
STEROID drugs , *CARDIOPULMONARY resuscitation , *SERIAL publications , *SUPERIOR mesenteric artery syndrome , *OPTICAL head-mounted displays , *EXTRACORPOREAL membrane oxygenation , *EMERGENCY medical services , *HEMORRHAGIC shock , *EMERGENCY medicine - Abstract
An introduction is presented in which the editor discusses articles in the issue on topics including early steroids in traumatic haemorrhagic shock, acute superior mesenteric vessel ischaemia, and rural and remote emergency medicine.
- Published
- 2023
- Full Text
- View/download PDF
35. The meaning of a high plasma free haemoglobin: retrospective review of the prevalence of haemolysis and circuit thrombosis in an adult ECMO centre over 5 years.
- Author
-
Pan, K. C., McKenzie, D. P., Pellegrino, V., Murphy, D., and Butt, W.
- Subjects
- *
APACHE (Disease classification system) , *CHI-squared test , *EXTRACORPOREAL membrane oxygenation , *HEMOGLOBINS , *HEMOLYSIS & hemolysins , *LONGITUDINAL method , *STATISTICS , *THROMBOSIS , *DATA analysis , *SEVERITY of illness index , *DATA analysis software , *HOSPITAL mortality , *MANN Whitney U Test , *KRUSKAL-Wallis Test - Abstract
Aims: In adults requiring extracorporeal membrane oxygenation (ECMO), we wanted to determine; i) the frequency of elevated plasma free haemoglobin (PFHb), ii) the reasons for circuit changes and iii) whether elevated PFHb was associated with higher in-hospital mortality. Materials and Methods: Patients requiring ECMO between January 2010 and August 2014 were identified from a prospectively collected ECMO database. Their scanned medical records and pathology results were reviewed. Relevant patient, biochemical and circuit data were collected on an Excel spreadsheet and analysed using Stata 13 (StataCorp, College Station, TX). The patients were analysed in three groups, depending on their peak PFHb during ECMO: ‘Normal PFHb’ (<0.1 g/L), ‘Low level PFHb’ (0.1 – 0.5 g/L), ‘High level PFHb’ (>0.5 g/L). Main Results: There were 184 ECMO runs (56 VV, 128 VA) – 61 ‘Normal PFHb’, 99 ‘Low level PFHb’, 24 ‘High level PFHb’. Circuit thrombosis (pump, oxygenator) or haemolysis requiring exchanges were significantly more common in VV ECMO compared to VA ECMO – 23.21% (13/56) vs. 0.78% (1/128), p<0.001. Elevated PFHb was associated with a longer duration of haemofiltration (p<0.001) and ECMO support (p<0.001). In-hospital mortality rates for the ‘Normal PFHb’, ‘Low level PFHb’ and ‘High level PFHb’ groups were 16.39% (10/61), 30.30% (30/99) and 37.50% (9/24), respectively, p=0.067. Conclusion: Elevated PFHb values during adult ECMO were common. Severe haemolysis or thrombosis requiring circuit changes were uncommon and occurred almost exclusively on VV ECMO. There was a non-statistically significant increase in in-hospital mortality with elevated PFHb and studies of larger registry data may clarify the prognostic value of PFHb in adult patients. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
36. Reports Outline Respiratory Therapy Study Findings from Baker Heart and Diabetes Institute (The Effect of Arterial Cannula Tip Position On Differential Hypoxemia During Venoarterial Extracorporeal Membrane Oxygenation).
- Subjects
EXTRACORPOREAL membrane oxygenation ,RESPIRATORY therapy ,CATHETERS ,HYPOXEMIA ,HEART - Abstract
Keywords: Melbourne; Australia; Australia and New Zealand; Angiology; Aorta; Arterial Cannula; Health and Medicine; Medical Devices; Physical Therapy and Rehabilitation Medicine; Respiratory Therapy EN Melbourne Australia Australia and New Zealand Angiology Aorta Arterial Cannula Health and Medicine Medical Devices Physical Therapy and Rehabilitation Medicine Respiratory Therapy 453 453 1 03/24/23 20230224 NES 230224 2023 FEB 26 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Researchers detail new data in Physical Therapy and Rehabilitation Medicine - Respiratory Therapy. Australia, Australia and New Zealand, Melbourne, Angiology, Aorta, Arterial Cannula, Health and Medicine, Medical Devices, Physical Therapy and Rehabilitation Medicine, Respiratory Therapy. [Extracted from the article]
- Published
- 2023
37. Nursing workforce, education, and training challenges to implementing extracorporeal membrane oxygenation services in Australian intensive care units: A qualitative substudy.
- Author
-
Ross P, Watterson J, Fulcher BJ, Linke NJ, Nicholson AJ, Ilic D, and Hodgson CL
- Subjects
- Humans, Australia, Intensive Care Units, Workforce, Extracorporeal Membrane Oxygenation, Nursing Staff, Burnout, Professional
- Abstract
Background: The use of extracorporeal membrane oxygenation (ECMO) is increasing in the management of critical care patients. ECMO service delivery requires an organisation-supported approach to ensure appropriate resources to deliver training, equipment, capacity, staffing, and the required model of care for quality care delivery. The aim of this nested substudy was to explore challenges specific to nursing staff in ECMO services in Australian intensive care units., Methods: This was a nested substudy within a qualitative study using semistructured focus group discussions conducted with 83 health professionals, which included 40 nurses. There were 14 focus groups across 14 ECMO centres participating in the binational ECMO (EXCEL) registry of Australia and New Zealand. An inductive thematic analysis focused on the nurse's experiences of the barriers and facilitators for nursing in providing an ECMO service., Results: Four themes emerged relating to the nurse's experience of implementing ECMO services: workforce requirements, workload demands, models of care, and level of experience. The complexity and intensity of caring for ECMO patients may need to be considered an additional factor in the burnout in critical care nurses. Current nursing ratios and responsibilities in critical care need to be considered, with the opportunity for the development of specialist advanced practitioner nursing roles., Conclusion: This study highlights the challenges for nursing in providing ECMO services in the intensive care setting. The complexity and intensity of ECMO is challenging and leads to concerns regarding burnout and workforce preparedness. New models of care need to be considered to mitigate the barriers for nursing identified across ECMO centres., (Copyright © 2021 Australian College of Critical Care Nurses Ltd. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
38. Paediatric heart transplantation in Australia comes of age: 21 years of experience in a national centre.
- Author
-
Alexander, P. M. A., Swager, A., Lee, K. J., Shipp, A., Konstantinov, I. E., Wilkinson, J. L., d'Udekem, Y., Brizard, C., and Weintraub, R. G.
- Subjects
- *
CONGENITAL heart disease diagnosis , *CORONARY disease , *DIAGNOSIS , *OPERATIVE surgery , *CONFIDENCE intervals , *DISEASES , *EXTRACORPOREAL membrane oxygenation , *CARDIAC patients , *HEART transplantation , *INTERNAL medicine , *EVALUATION of medical care , *MEDICAL referrals , *MEDICAL practice , *PEDIATRICS , *POSTOPERATIVE care , *SERIAL publications , *SURVIVAL , *DATA analysis , *PROPORTIONAL hazards models , *HEALTH literacy , *TREATMENT duration , *DATA analysis software - Abstract
Background Heart transplantation ( HT) is established therapy for end-stage heart failure in children with cardiomyopathy or congenital heart disease. Aims This review summarises experience at a national referral centre since the first local transplant. Methods Medical records of children referred for HT between 1 April 1988 and 1 January 2010 were retrospectively reviewed. All patients listed for HT were included. Survival analysis was used to summarise wait-list time to death/transplant, and separately, time to death in HT patients. Results One hundred and thirty-nine children were accepted on to the HT waiting list during the study (median age 7.7 (interquartile range ( IQR) 2.5, 13.6) years), of whom 93 underwent HT (median age 10.9 ( IQR 4.4, 14.6) years). Wait-list mortality was 32% (45 of 139 patients), lowest among children aged >10 years at listing ( P < 0.001). Median time to HT was 69 days (range 29-146). Survival post-transplantation was 90% (95% confidence interval 82-95) at 1 year, 82% (72-89%) at 5 years and 68% (50-80%) at 10 years. Increasing case complexity over the study period included pre- and post-transplant circulatory support, management of pulmonary hypertension and introduction of ABO-incompatible HT for infants. Post-transplant survival did not vary according to age, pre-transplant diagnosis or use of pre-transplant circulatory support (all P > 0.05). Conclusions Results of paediatric HT in Australia are comparable with international results, despite limitations of geographic isolation, small population and low organ donation rate. Increasing case complexity has not impacted on post-transplant survival. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
39. Unexpected survival after deliberate phosphine gas poisoning: An Australian experience of extracorporeal membrane oxygenation rescue in this setting.
- Author
-
A Farrar R, B Justus A, A Masurkar V, and M Garrett P
- Subjects
- Adult, Australia, Female, Humans, Phosphines, Shock, Cardiogenic, Extracorporeal Membrane Oxygenation methods, Gas Poisoning, Pesticides
- Abstract
Phosphine poisoning is responsible for hundreds of thousands of deaths per year in countries where access to this pesticide is unrestricted. Metal phosphides release phosphine gas on contact with moisture, and ingestion of these tablets most often results in death despite intensive support. A 36-year-old woman presented to a regional hospital after ingesting multiple aluminium phosphide pesticide tablets and rapidly developed severe cardiogenic shock. In this case, serendipitous access to an untested Extracorporeal Membrane Oxygenation (ECMO) service of a regional hospital effected a successful rescue and prevented the predicted death. We discuss the toxicology, management and the evidence for and against using ECMO in this acute poisoning.
- Published
- 2022
- Full Text
- View/download PDF
40. Population Pharmacokinetics of Vancomycin in Critically Ill Adult Patients Receiving Extracorporeal Membrane Oxygenation (an ASAP ECMO Study).
- Author
-
Cheng V, Abdul-Aziz MH, Burrows F, Buscher H, Cho YJ, Corley A, Diehl A, Gilder E, Jakob SM, Kim HS, Levkovich BJ, Lim SY, McGuinness S, Parke R, Pellegrino V, Que YA, Reynolds C, Rudham S, Wallis SC, Welch SA, Zacharias D, Fraser JF, Shekar K, and Roberts JA
- Subjects
- Adult, Anti-Bacterial Agents pharmacokinetics, Australia, Critical Illness therapy, Humans, Extracorporeal Membrane Oxygenation, Vancomycin pharmacokinetics
- Abstract
Our study aimed to describe the population pharmacokinetics (PK) of vancomycin in critically ill patients receiving extracorporeal membrane oxygenation (ECMO), including those receiving concomitant renal replacement therapy (RRT). Dosing simulations were used to recommend maximally effective and safe dosing regimens. Serial vancomycin plasma concentrations were measured and analyzed using a population PK approach on Pmetrics . The final model was used to identify dosing regimens that achieved target exposures of area under the curve (AUC
0-24 ) of 400-700 mg · h/liter at steady state. Twenty-two patients were enrolled, of which 11 patients received concomitant RRT. In the non-RRT patients, the median creatinine clearance (CrCL) was 75 ml/min and the mean daily dose of vancomycin was 25.5 mg/kg. Vancomycin was well described in a two-compartment model with CrCL, the presence of RRT, and total body weight found as significant predictors of clearance and central volume of distribution ( Vc ). The mean vancomycin renal clearance and Vc were 3.20 liters/h and 29.7 liters respectively, while the clearance for patients on RRT was 0.15 liters/h. ECMO variables did not improve the final covariate model. We found that recommended dosing regimens for critically ill adult patients not on ECMO can be safely and effectively used in those on ECMO. Loading doses of at least 25 mg/kg followed by maintenance doses of 12.5-20 mg/kg every 12 h are associated with a 97-98% probability of efficacy and 11-12% probability of toxicity, in patients with normal renal function. Therapeutic drug monitoring along with reductions in dosing are warranted for patients with renal impairment and those with concomitant RRT. (This study is registered with the Australian New Zealand Clinical Trials Registry [ANZCTR] under number ACTRN12612000559819.).- Published
- 2022
- Full Text
- View/download PDF
41. Long-term outcomes of adults with acute respiratory failure treated with veno-venous extracorporeal membrane oxygenation.
- Author
-
Gray EL, Forrest P, Southwood TJ, Totaro RJ, Plunkett BT, and Torzillo PJ
- Subjects
- Adult, Australia, Humans, Male, Retrospective Studies, Extracorporeal Membrane Oxygenation, Respiratory Distress Syndrome therapy, Respiratory Insufficiency therapy
- Abstract
Veno-venous extracorporeal membrane oxygenation is increasingly used for severe but potentially reversible acute respiratory failure in adults; however, there are limited data regarding long-term morbidity. At our institution, most patients requiring veno-venous extracorporeal membrane oxygenation have been followed up by a single physician. Our primary aim was to describe the serial long-term morbidity for respiratory, musculoskeletal and psychological functioning., A retrospective audit of inpatient and outpatient medical records was conducted. A total of 125 patients treated with veno-venous extracorporeal membrane oxygenation for primary respiratory failure were included. The patients were young (mean (standard deviation) age 43.7 (4.1) years), obese (mean (standard deviation) body mass index 30.8 (10.4) kg/m
2 ), and mostly were male (59%). Most patients (60%) had no comorbidities., The survival rate to discharge was 70%, with body mass index and the number of comorbidities being independent predictors of survival on multiple logistic regression analysis. Over half (57%) of the Australian survivors had regular outpatient follow-up. They had a median of three reviews (range 1-9) over a median of 11.8 months (range 1.5-79) months. Breathlessness and weakness resolved in most within six months, with lung function abnormalities taking longer to resolve. Over half (60%) returned to employment within six months of discharge. Over a quarter (29%) displayed symptoms of anxiety, depression or post-traumatic stress disorder.- Published
- 2021
- Full Text
- View/download PDF
42. Ventricular Tachycardia Storm Ablation With Pre-Emptive Circulatory Support by Extracorporeal Membrane Oxygenation: Australian Experience.
- Author
-
Campbell T, Bennett RG, Lee V, Turnbull S, Eslick A, Kruit N, Pudipeddi A, Hing A, Kizana E, Thomas SP, and Kumar S
- Subjects
- Australia epidemiology, Humans, Middle Aged, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Catheter Ablation, Extracorporeal Membrane Oxygenation, Tachycardia, Ventricular surgery
- Abstract
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can provide circulatory support in high-risk patients undergoing drug refractory ventricular tachycardia (VT) ablation procedures. We report experience using VA-ECMO in a pre-emptive approach for high-risk patients with VT storm and previously ineffective ablation procedures., Methods and Results: Four (4) patients with drug refractory ventricular tachycardia (mean age 61±3 years; left ventricular ejection fraction 21±5%) presenting for VT ablation had pre-emptive VA-ECMO. All patients during current admission had VT storm. Pre-ablation, 22 total monomorphic VTs (cycle length 402±69 ms) were induced or spontaneously observed (median of 4, IQR
25-75% 1-6). At the end of the procedure, 86% of all inducible VTs were rendered non-inducible. Median hospitalisation following VA-ECMO supported ablation was 5 days (IQR25-75% 3-12). During follow-up (median 138 days [IQR25-75% 57-277]), VT recurred in one patient as an isolated episode reverted by anti-tachycardia pacing. There was a 99% reduction in VT burden post ablation. One (1) patient died of cardiogenic shock within 24 hours whilst still on VA-ECMO, all other patients were successfully weaned off support and discharged. Two (2) patients underwent cardiac transplantation at 199 and 512 days post ablation following implantation of ventricular assist devices for worsening heart failure., Conclusions: The pre-emptive use of VA-ECMO for high-risk patients undergoing catheter ablation for VT storm was found to be effective in maintaining haemodynamic status, and allowing successful mapping and catheter ablation for VT., (Crown Copyright © 2020. Published by Elsevier B.V. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
43. The expanding role of extracorporeal membrane oxygenation retrieval services in Australia.
- Author
-
Edelman, J. J. B., Wilson, M. K., Vallely, M. P., Bannon, P. G., McKay, G., Robertson, S. J., Hislop, R., Wong, C., Cartwright, B. L., Forrest, P., Torzillo, P. J., and Edelman, Jjb
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *MEDICAL referrals , *TRANSPORTATION of patients , *LIFE support systems in critical care , *UNIVERSITY hospitals , *HOSPITAL admission & discharge , *TIME , *SPECIALTY hospitals - Abstract
Herein we detail the cases of three patients transferred on veno-arterial extracorporeal membrane oxygenation (VA ECMO) from a tertiary referral hospital to an ECMO centre. We highlight the benefits of such a transfer and offer this as a model of care for unwell patients likely to require a prolonged period of ECMO support. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
44. Prospective Surveillance of Pediatric Invasive Group A Streptococcus Infection.
- Author
-
Ching NS, Crawford N, McMinn A, Baker C, Azzopardi K, Brownlee K, Lee D, Gibson M, Smeesters P, Gonis G, Ojaimi S, Buttery J, and Steer AC
- Subjects
- Anti-Bacterial Agents therapeutic use, Australia epidemiology, Child, Child, Preschool, Extracorporeal Membrane Oxygenation, Female, Humans, Incidence, Infant, Infant, Newborn, Male, Population Surveillance, Prospective Studies, Respiratory Therapy, Severity of Illness Index, Streptococcal Infections classification, Streptococcal Infections complications, Streptococcal Infections drug therapy, Streptococcal Infections epidemiology, Streptococcus pyogenes
- Abstract
Background: Invasive group A Streptococcus (GAS) disease has an incidence in high-income countries of 3 to 5 per 100000 per annum and a case-fatality ratio of 10% to 15%. Although these rates are comparable to those of invasive meningococcal disease in Australia before vaccine introduction, invasive GAS disease currently requires reporting in only 2 jurisdictions., Methods: Data were collected prospectively through active surveillance at the Royal Children's Hospital, Melbourne (October 2014 to September 2016). Isolation of GAS from a sterile site was required for inclusion. Comprehensive demographic and clinical data were collected, and emm typing was performed on all isolates. Disease was considered severe if the patient required inotropic support or mechanical ventilation., Results: We recruited 28 patients. The median age of the patients was 3.5 years (range, 4 days to 11 years). Ten (36%) patients had severe disease. Fifteen (54%) children had presented to a medical practitioner for review in the 48 hours before their eventual admission, including 7 of the 10 patients with severe GAS infection. Complications 6 months after discharge persisted in 21% of the patients. emm1 was the most common emm type (29%)., Conclusion: We found considerable short- and longer-term morbidity associated with pediatric invasive GAS disease in our study. Disease manifestations were frequently severe, and more than one-third of the patients required cardiorespiratory support. More than one-half of the patients attended a medical practitioner for assessment but were discharged in the 48-hour period before admission, which suggests that there might have been a window for earlier diagnosis. Our methodology was easy to implement as a surveillance system., (© The Author(s) 2017. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.